Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Evoq Remedies Ltd.
Swot
Evoq Remedies Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Evoq Remedies Ltd. has 12 Strengths, 11 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(12)
Weakness
(11)
Opportunity
(0)
Threats
(0)
Others
(1)
Companies with no Debt
Relative Outperformance versus Industry over 1 Month
Stocks gaining versus previous close, open price and RSI
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Companies with Zero Promoter Pledge
Stock gained more than 20% in one month
High Volume, High Gain
Top Gainers
Volume Shockers
PE higher than Industry PE
High PE (PE > 40)
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Annual net profit declining for last 2 years
Highest fall from 52 Week High
Declining profitability: Falling ROCE
Stocks Underperforming their Industry Price Change in the Quarter
Dragonfly Doji (Bullish Reversal)
